
Greece steps up HPV prevention with vaccination and digital tools as preventable cancer cases rise
Greece is intensifying its fight against human papillomavirus (HPV), a preventable cause of several cancers, by combining mass vaccination campaigns with digital tracking systems to ensure no child or adolescent misses protection. On Monday, health officials, scientists, and civil society representatives gathered in Athens to assess progress and outline next steps, warning that lapses in prevention could leave young people vulnerable to preventable disease.
The push comes as Greece joins a growing number of European countries using digital registries to monitor HPV vaccination coverage and identify unvaccinated individuals. At a roundtable discussion hosted by ygeiamou.gr, policymakers emphasized the need to eliminate missed opportunities for immunization, particularly among adolescents. “We must ensure that every child and teenager in Greece has access to HPV vaccination,” said a senior health ministry official. “Digital tools allow us to track coverage in real time and intervene where uptake is low.”
HPV is responsible for nearly all cases of cervical cancer and contributes to cancers of the throat, anus, and genitals. The virus is preventable through vaccination, yet uptake remains uneven across Europe. Greece’s initiative follows a 2025 European Commission recommendation urging member states to achieve 90% vaccination coverage for girls and boys by 2030. Current data from the Greek National Public Health Organization (EODY) show that only 68% of 15-year-old girls and 52% of 15-year-old boys have received at least one dose of the HPV vaccine, well below the target.
The new strategy includes automated reminders via SMS and email, school-based vaccination programs, and partnerships with pediatricians to counsel parents. “We are using technology not just to record data, but to close gaps in care,” said Dr. Maria Papadopoulou, an epidemiologist at the University of Athens. “Every unvaccinated child represents a missed chance to prevent cancer.”
The initiative also addresses misinformation, which has contributed to vaccine hesitancy. Public health campaigns are being rolled out in schools and on social media, featuring testimonials from cancer survivors and healthcare workers. “We are countering myths with facts,” said a representative from the Greek Cancer Society. “HPV vaccination is safe, effective, and saves lives.”
Greece’s move reflects a broader European trend. Earlier this month, the European Centre for Disease Prevention and Control (ECDC) reported that HPV vaccination rates had stagnated in several countries due to logistical challenges and misinformation. The ECDC called for coordinated action, including digital tracking and school-based programs, to reverse the trend.
With summer travel and social gatherings increasing, health authorities are urging parents to schedule vaccinations before the new school year. “There is no better time than now to protect our children,” said Papadopoulou. “HPV doesn’t wait—and neither should we.”